Press Releases
Biotechnology
-
Contur ELN from Accelrys Powers UK's Largest Trial of Academic Electronic Lab Notebooks
Contur ELN from Accelrys Powers UK's Largest Trial of Academic Electronic Lab Notebooks Up to 400 scientists at 16 universities can access and assess low-cost, easy-to-deploy notebook, leveraging Cloud- and Web-based information sharing ...
-
MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan
MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan PR Newswire - Widespread Availability of MicroRNA Research Tools could Reduce the Opportunities for the Services Sector LONDON , May 23,...
-
MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan
MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan Widespread Availability of MicroRNA Research Tools could Reduce the Opportunities for the Services Sector PR Newswire LONDON , May 23,...
-
Patheon announces date of second quarter fiscal 2012 financial results
Patheon announces date of second quarter fiscal 2012 financial results PR Newswire TORONTO , May 23, 2012 /PRNewswire/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and manufacturing services to the global...
-
Monsanto CTO Robb Fraley Defines New Growth Layers For Company's R&D Pipeline
Monsanto CTO Robb Fraley Defines New Growth Layers For Company's R&D Pipeline Company unveils new BioDirect™ biological technology, discusses opportunities spanning geographies and technologies beyond breeding and biotechnology PR Newswire...
-
Monsanto Company to Purchase Planting Technology Developer Precision Planting, a Leader in Delivering Yield Through Technology
Monsanto Company to Purchase Planting Technology Developer Precision Planting, a Leader in Delivering Yield Through Technology Technology Complements Integrated Farming Systems™ Vision, Would Strengthen Monsanto's Prescription Offering ...
-
Antibody Drugs: Technologies and Global Markets
Antibody Drugs: Technologies and Global Markets PR Newswire NEW YORK , May 23, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Antibody Drugs: Technologies and Global...
-
Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications
Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications PR Newswire NEW YORK , May 23, 2012 /PRNewswire/ -- Reportlinker.com...
-
PAREXEL International To Present At Goldman Sachs Healthcare Conference And Jefferies Healthcare Conference
PAREXEL International To Present At Goldman Sachs Healthcare Conference And Jefferies Healthcare Conference PR Newswire BOSTON , May 23, 2012 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it...
-
Health-Conscious Storable Food Company GOFoods Global Commits to Use of Non-GMO Ingredients, Endorses Mandatory Labeling and Partners with JustLabelIt.org to provide a Nutriversal Seal on all GOFoods Global Packaging
Health-Conscious Storable Food Company GOFoods Global Commits to Use of Non-GMO Ingredients, Endorses Mandatory Labeling and Partners with JustLabelIt.org to provide a Nutriversal Seal on all GOFoods Global Packaging GOFoods Global, creator...
-
Antibacterials Market to 2017 - Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential
Antibacterials Market to 2017 - Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential PR Newswire NEW YORK , May 23, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market...
-
Zytoprotec Completes Phase I/II Trial of Novel Dialysate, Enters Into Negotiations with Global ...
Vienna, Austria, May 23, 2012 / B3C newswire / – Zytoprotec , a company developing drugs based on active cytoprotection, today announced the completion of a Phase I/II clinical trial with its lead product, PD-protec™ . The product is developed...
-
'KOREA PACK 2012' for Packing process industry to be held at KINTEX
'KOREA PACK 2012' for Packing process industry to be held at KINTEX PR Newswire ILSAN, South Korea , May 23, 2012 /PRNewswire/ -- The 17th International Packaging Exhibition (KOREA PACK 2012) had an opening ceremony on 22nd at KINTEX,...
-
Galapagos receives transparency notification
MECHELEN, BELGIUM -- (Marketwire) -- 05/23/12 -- Galapagos NV (Euronext: GLPG) announced today that it has received a transparency notification pursuant to the Belgian transparency legislation (Belgian Act of 2 May 2007) concerning major holdings in...
-
GeneLink Reports First Quarter 2012 Financial Results
GeneLink Reports First Quarter 2012 Financial Results PR Newswire ORLANDO, Fla. , May 22, 2012 /PRNewswire/ -- GeneLink, Inc. (OTCBB: GNLK.OB, "the Company," or "GeneLink"), a leading consumer genomics biotech company, reports...
Follow us
What people say
Our Partners
© 2005-2012